.png)
MedPage Today) -- A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial...
7200 Powers Ave. #151 Jacksonville, Florida 32217
1-904-729-1091
admin@jacemembers.com
Copyright © 2023 news24. All Rights Reserved
